|
Nov 2
|
McKesson (MCK) Beats on Q2 Earnings, Raises '23 EPS View
|
|
Nov 2
|
1 Stock Down 15% This Year to Buy and Hold Forever
|
|
Nov 2
|
Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV
|
|
Nov 2
|
The Abbott Laboratories (ABT) Company: A Short SWOT Analysis
|
|
Oct 11
|
3 Reasons to Buy Abbott Laboratories Stock
|
|
Oct 11
|
Abbott Laboratories's Dividend Analysis
|
|
Oct 10
|
What's in Store for Abbott Laboratories (ABT) in Q3 Earnings?
|
|
Oct 10
|
Investing in Abbott Laboratories (NYSE:ABT) five years ago would have delivered you a 52% gain
|
|
Oct 9
|
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
|
|
Oct 5
|
(ABT) Ascends While Market Falls: Some Facts to Note
|
|
Oct 4
|
With 76% ownership, Abbott Laboratories (NYSE:ABT) boasts of strong institutional backing
|
|
Oct 3
|
The Zacks Analyst Blog Highlights Abbott Laboratories, Koninklijke Philips and Smith & Nephew
|
|
Oct 2
|
3 Medical Product Stocks With Solid Dividend Yield: ABT & Others
|
|
Oct 2
|
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
|
|
Sep 12
|
Is Abbott Laboratories a Buy?
|
|
Sep 12
|
Investors Will Want Abbott Laboratories' (NYSE:ABT) Growth In ROCE To Persist
|
|
Sep 11
|
Abbott (ABT) Outpaces Stock Market Gains: What You Should Know
|
|
Sep 11
|
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
|
|
Sep 11
|
Less Is More: Abbott’s Approach to Packaging Innovation
|
|
Sep 9
|
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
|